Env from EIAV vaccine delicately regulates NLRP3 activation via attenuating NLRP3-NEK7 interaction
Xing Yuan GuoiD, Cong LiuiD, Yuhong WangiD, Hongxin LiiD, Saiwen Ma, Na LeiiD, Huiling ReniD, Yuezhi LiniD, Xiaojun WangiD
Abstract
The current equine infectious anemia virus (EIAV) vaccine causes attenuation of the inflammatory response to an appropriate level, compared to that produced by virulent EIAV. However, how the EIAV vaccine finely regulates the inflammatory response remains unclear. Using a constructed NLRP3-IL-1{beta} screening system, viral proteins from two EIAV strains (the attenuated vaccine and its virulent mother strain) were examined separately. Firstly, EIAV-Env was screened to direct binding P2X7(R) with notable K+ efflux trans-cellularly. Secondly, EIAV-Env was found to bind NLRP3 and/or NEK7 to trigger aggregation of NLRP3-NEK7 to form NLRP3-NEK7 complex in cells. Comparison of the two strains, we observed a significant reduction on vaccine-Env-initiated NLRP3-NEK7 complex formation, with no difference in Env triggering P2X7(R)-mediated ion fluxes. Thirdly, reciprocally mutation on four stable varied amino acids between two strains produced an anticipated outcome on NLRP3-IL-1{beta}-axis activation. As the attenuated vaccine was shown evolved as a natural quasispecies of the virulent EIAV, its precise and adaptable regulation via spatial proximity-dependent intracellular activation might present a "win-win" virus-host adaption, offering an alternative strategy on HIV vaccine development. Author SummaryHere, we report that EIAV-Env mediates NLRP3 inflammasome activation through two distinct pathways. The first pathway involves a transcellular mechanism driven by K+ flux, which couples Env-P2X7 interaction. The second pathway entails direct intracellular binding between Env and NLRP3, promoting the assembly of NLRP3-NEK7 and subsequent inflammasome formation. Notably, we observed a marked difference in NLRP3 inflammasome activation between the vaccine and virulent strains, which was reflected in the extent of Env-mediated NLRP3-NEK7 aggregation. This study not only enhances our understanding of lentivirus-host immune interactions but also contributes to the broader discourse on virus evolution and host-induced inflammation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 0.60
- Field percentile
- top 40%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense
- Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.
N. J. Kingston, J. S. Snowden, … N. J. Stonehouse·bioRxiv·Jan 30, 2023
- H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves
Carine K. Souza, Jefferson José da Silva Santos, … Amy L. Vincent Baker·Journal of VirologyPeer-reviewed·Oct 8, 2026
- Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice.
Sonia Jangra, Alexander Lamoot, … Michael Schotsaert·Frontiers in ImmunologyPeer-reviewed·Apr 22, 2024
- Direct Virus-Bacteria Binding Enhances Streptococcus equi subsp. zooepidemicus Colonisation and Bacterial-Driven Immune Activation During H3N8 Equine Influenza A Virus Co-Infection
Askar K. Alshammari, Meshach Maina, … Stephen P. Dunham·bioRxiv·May 19, 2026
- The Infectious Bronchitis Virus Coronavirus Envelope Protein Alters Golgi pH to Protect Spike Protein and Promote Release of Infectious Virus
J. W. Westerbeck, C. E. Machamer·bioRxiv·Oct 11, 2018